Mostafa Abdulla Elsayed Mahmoud
Asst. Professor
Agnucaston and Clomiphen Citrate in Infertile Patients with Polycystic Ovaries
• 2013
Publication Information
Authors
Elsayed MA*
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Objectives: To study the effect of agnucaston with clomiphen citrate in infertile patients with polycystic ovaries.
Study type: Controlled trial.
Materials and Methods: One hundred infertile cases with polycystic ovaries randomized into two groups fifty
(50) cases received clomiphen citrate 50 mg from second day of menstruation two tablets per day for 5 days in
addition with agnucaston (agnus castus, Binoreca) two tablets per day from the first day of menstruation for 14 days
the other group received only clomiphen citrate 50 mg two tablets per day from second day for 5 days.
Results: Group 1(combined agnucaston with clomiphen citrate the pregnancy rate is 30 out of 50 (60%) while
the second group the (clomiphen only group) pregnancy rate is 15 out of 50 (30%).
Study type: Controlled trial.
Materials and Methods: One hundred infertile cases with polycystic ovaries randomized into two groups fifty
(50) cases received clomiphen citrate 50 mg from second day of menstruation two tablets per day for 5 days in
addition with agnucaston (agnus castus, Binoreca) two tablets per day from the first day of menstruation for 14 days
the other group received only clomiphen citrate 50 mg two tablets per day from second day for 5 days.
Results: Group 1(combined agnucaston with clomiphen citrate the pregnancy rate is 30 out of 50 (60%) while
the second group the (clomiphen only group) pregnancy rate is 15 out of 50 (30%).